Search - tctmd.com

Displaying 721 - 740 of 4251

Sort: Relevancy | Date

Presentation ECHO 2016

Know your Cardiomyopathies: Echo Clues to Diagnosis

Presenter: Michael H. Picard

March 21, 2016

Presentation ECHO 2016

Interesting Cases: Diagnostic Dilemma

Presenter: Jae K. Oh

March 21, 2016

Presentation ECHO 2016

Hypertrophic Cardiomyopathy: Diagnosis and Management

Presenter: Gerard P. Aurigemma

March 21, 2016

Presentation ECHO 2016

Echo Assessment of Diastolic FunctionPart 1 in 15 minutes

Presenter: Jae K. Oh

March 21, 2016

Presentation ECHO 2016

Echo Assessment of Diastolic Function III: Putting Diastolic Function Assessment Into Clinical Practice

Presenter: Gerard P. Aurigemma

March 21, 2016

Presentation ECHO 2016

Assessing Patients after Transcatheter Aortic Valve Replacement: VARC3

Presenter: Philippe Pibarot

March 21, 2016

News Daily News

FDA Issues Class I Recall for Intra-Aortic Balloon Catheter and Percutaneous Insertion Kits

Michael O'Riordan

March 18, 2016

News Industry News

Edwards Lifesciences Receives Approval For SAPIEN 3 Valve In Japan

March 16, 2016

News Daily News

卒中率下降使人质疑是否有必要在 TAVR 中置入血栓预防设备

Michael O'Riordan

March 14, 2016

News Daily News

Bajan los Índices de ACV y Aumentan las Dudas sobre los Dispositivos de Protección Embólica en las Intervenciones TAVR

Michael O'Riordan

March 14, 2016

News Daily News

As Stroke Rates Fall, Questions Mount for Embolic Protection Devices in TAVR

Michael O'Riordan

March 14, 2016

News Industry News

Successful Transapical Access and Closure Clinical Test Performed in 6 Consecutive Invivo Procedures Using the Heartstitch TA

March 09, 2016

News Daily News

Risk Model Improves Practical Prediction of In-Hospital Mortality After TAVR

L.A. McKeown

March 08, 2016

News Industry News

LivaNova, PLC Announces the First U.S. Implants of Perceval, the Only Sutureless Valve for Aortic Valve Replacement Surgery

March 08, 2016

News Industry News

Endologix Announces First Patients in Japan Treated With Nellix® EndoVascular Aneurysm Sealing System

March 08, 2016

Presentation

Development and Validation of a Risk Prediction Model for In-hospital Mortality After TAVR

Presenter: Fred H. Edwards

March 08, 2016

News Daily News

小组认为经颈动脉 TAVR 是可行的，且可取代经股动脉的其他替代方案

Shelley Wood

March 07, 2016

News Daily News

Un Grupo asegura que la TAVR Transcarotídea es Viable y Podría Reemplazar Otras Alternativas al Abordaje Transfemoral

Shelley Wood

March 07, 2016

News Daily News

Transcarotid TAVR Is Feasible, Could Supplant Other Alternatives to Transfemoral, Group Says

Shelley Wood

March 07, 2016

News Industry News

BioStable Science & Engineering Announces CE Mark Approval for the HAART 300 Aortic Annuloplasty Device

March 07, 2016

Advertisement

Know your Cardiomyopathies: Echo Clues to Diagnosis

Interesting Cases: Diagnostic Dilemma

Hypertrophic Cardiomyopathy: Diagnosis and Management

Echo Assessment of Diastolic FunctionPart 1 in 15 minutes

Echo Assessment of Diastolic Function III: Putting Diastolic Function Assessment Into Clinical Practice

Assessing Patients after Transcatheter Aortic Valve Replacement: VARC3

FDA Issues Class I Recall for Intra-Aortic Balloon Catheter and Percutaneous Insertion Kits

Edwards Lifesciences Receives Approval For SAPIEN 3 Valve In Japan

卒中率下降使人质疑是否有必要在 TAVR 中置入血栓预防设备

Bajan los Índices de ACV y Aumentan las Dudas sobre los Dispositivos de Protección Embólica en las Intervenciones TAVR

As Stroke Rates Fall, Questions Mount for Embolic Protection Devices in TAVR

Successful Transapical Access and Closure Clinical Test Performed in 6 Consecutive Invivo Procedures Using the Heartstitch TA

Risk Model Improves Practical Prediction of In-Hospital Mortality After TAVR

LivaNova, PLC Announces the First U.S. Implants of Perceval, the Only Sutureless Valve for Aortic Valve Replacement Surgery

Endologix Announces First Patients in Japan Treated With Nellix® EndoVascular Aneurysm Sealing System

Development and Validation of a Risk Prediction Model for In-hospital Mortality After TAVR

小组认为经颈动脉 TAVR 是可行的，且可取代经股动脉的其他替代方案

Un Grupo asegura que la TAVR Transcarotídea es Viable y Podría Reemplazar Otras Alternativas al Abordaje Transfemoral

Transcarotid TAVR Is Feasible, Could Supplant Other Alternatives to Transfemoral, Group Says

BioStable Science & Engineering Announces CE Mark Approval for the HAART 300 Aortic Annuloplasty Device

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content